Check Franchise Availability
Instant Franchise Enquiry | Whatsapp
Download Product List

INTRAGLY-FB INHALER 120MD

Composition:
GLYCOPYRROLATE IP 9mcg Formoterol fumarate Dihydrate IP eqv to formoterol fumarate 4.8mcg budesonoide IP 160mcg suspended in propellant HFA 134a q.s
Indication:
Used for maintenance treatment of COPD, including chronic bronchitis and emphysema. Helps improve breathing, reduce airway inflammation, and prevent COPD flare-ups
Packing:
( 60MG+WFI )
Pack Type:
inhaler

Description

IntraGly-FB Inhaler │ Triple Therapy 120 Doses │ Intra Life

 

IntraGly-FB Inhaler by Intra Life is a prescription triple-combination respiratory formulation containing Glycopyrrolate, Formoterol Fumarate and Budesonide. It combines a long-acting muscarinic antagonist (LAMA), long-acting beta-2 agonist (LABA) and inhaled corticosteroid (ICS).

This class of inhaled triple therapy is used for maintenance treatment in selected adults with chronic obstructive pulmonary disease (COPD), where the specific product is authorized and prescribed. Glycopyrrolate blocks muscarinic-mediated bronchoconstriction; Formoterol supports long-acting bronchodilation by stimulating beta-2 receptors; and Budesonide acts as an inhaled anti-inflammatory corticosteroid.

IntraGly-FB is not a rescue inhaler for sudden breathing attacks. Confirm approved indications, active ingredient strengths, dosing regimen and precautions from the official label before publishing.


Indications and Therapeutic Uses

 

Clinical area Explanation
COPD maintenance treatment Triple inhaled therapy may be prescribed for selected adults needing ongoing maintenance treatment.
Persistent airflow limitation Long-acting bronchodilators help keep airways more open over time.
COPD exacerbation management In selected patients, adding an ICS may reduce exacerbation frequency; individual risks and benefits vary.
Chronic bronchitis / emphysema with COPD May be part of the maintenance plan when approved and clinically appropriate.

Triple inhaled therapy is not suitable for all COPD patients. Budesonide-containing COPD therapy may increase pneumonia risk. Do not claim approval for asthma or other conditions without product-specific evidence.


Mechanism of Action – Step by Step

 

  • Inhalation: Medication is delivered through the prescribed inhaler device to the airways.
  • Glycopyrrolate (LAMA): Blocks airway muscarinic receptors, particularly M3-mediated smooth muscle contraction, promoting bronchodilation.
  • Formoterol Fumarate (LABA): Stimulates beta-2 adrenergic receptors, increasing intracellular cyclic AMP and relaxing airway smooth muscle.
  • Budesonide (ICS): Activates glucocorticoid receptors, reducing airway inflammatory signaling.
  • Combined maintenance action: Produces long-acting bronchodilation and anti-inflammatory treatment in appropriately selected patients.

Product Packing and Specifications

 

Parameter Details
Brand IntraGly-FB
Company Intra Life
Active ingredients Glycopyrrolate; Formoterol Fumarate; Budesonide
Exact strengths Verify approved label (not clearly visible)
Form Inhaler; exact device mechanism to confirm
Pack size 120 Metered Doses
Drug class LAMA + LABA + ICS
Segment Respiratory / Pulmonology
Route Oral inhalation
Prescription status Rx
Storage As stated in approved product instructions

 


Dosage, Administration and Safety

 

A fixed dose or number of puffs for IntraGly-FB cannot be determined safely from the photograph. Use the approved prescribing leaflet and prescriber instructions. The following describes general inhaler principles and does not replace device-specific training.

  • Check your prescription, prescribed number of inhalations and frequency.
  • Check the inhaler name, expiration date, mouthpiece and any dose counter.
  • Prepare the device exactly as directed, including shaking or priming if required.
  • Breathe out gently away from the mouthpiece.
  • Use the specific coordinated actuation and inhalation technique taught for this device.
  • Repeat only if an additional inhalation is prescribed.
  • Rinse mouth with water and spit after inhalation to reduce oral thrush risk.
  • Clean and store the device as instructed by the manufacturer.
  • Possible side effects: dry mouth, hoarseness, oral candidiasis, tremor, headache or palpitations.
  • Important risks: pneumonia in certain COPD patients, paradoxical bronchospasm, urinary retention and worsening narrow-angle glaucoma in susceptible people.
  • Seek urgent care for severe breathing difficulty, chest pain, serious allergy or sudden worsening after inhalation.
  • Not for acute symptom relief; use a prescribed rescue treatment and emergency plan if needed.

 


FAQ

 

What is IntraGly-FB Inhaler used for?
Triple therapy of this class is used for COPD maintenance in selected patients, subject to product-specific authorization.

What is its composition?
Glycopyrrolate, Formoterol Fumarate and Budesonide; exact strengths require label verification.

Is it a triple therapy inhaler?
Yes. It combines LAMA, LABA and ICS components.

How many doses are included?
The packaging states 120 metered doses.

Can it treat a sudden asthma attack?
No. This is not an emergency rescue inhaler.

What are potential adverse effects?
Oral thrush, hoarseness, dry mouth, tremor, palpitations and others; serious risks need professional review.

Should I rinse my mouth after inhalation?
Yes. Rinsing and spitting helps reduce steroid-associated oral thrush.

What therapeutic segment does it belong to?
Respiratory / Pulmonology.

Is it available without a prescription?
The pack states Rx; supply must comply with prescription requirements.

How can distributors enquire?
Contact Intra Life through verified official trade channels.

Logo 1
Logo 2
Logo 3
Logo 4 loading=
Logo 5
Logo 6
Logo 7
Logo 1
Logo 2
Logo 3
Logo 4
Logo 5
Logo 6
Logo 7

AWARDS ACHIEVEMENTS

Virender

Mr. Virender Sehwag

Beauty

BEAUTY ICON & STYLE DIVA Mrs. SHILPA SHETTY KUNDRA.

Jackie

Mr. Jackie Shroff

Most Promising

Most Promising Brand and Quality

National

National Healthcare Excellence Award 2016

Sonu

Excellence in Pharmaceutical & Nutraceutical 2019

Chief

Chief Minister of Maharashtra, Sri Eknath Shinde Ji

Nitin

Shri Nitin Gadkari, Transport & Highways Minister

Gujarat Chief

Gujarat's Chief Minister, Bhupendrabhai Patel Ji,

Sonu Sharma

Mr. Sonu Sharma

Harbajan

Mr. Harbhajan Singh

Sonutwo

Mr. Sonu Sood

Nora Fatehi

Ms. Nora Fatehi

Shivaraj

Mr. Shivaraj Kumar

Anup

Mr. Anup Soni

Sunny

Sunny Leone

Hussain

Hussain Kuwajerwala

Tamanna Bhatia

Tamanna Bhatia

Malaika

Malaika Arora

Tusshar

Tusshar Kapoor

Sreesanth

Mr. S. Sreesanth

Neha Dupia

NEHA DUPIA

Virender

Mr. Virender Sehwag

Beauty

BEAUTY ICON & STYLE DIVA Mrs. SHILPA SHETTY KUNDRA.

Jackie

Mr. Jackie Shroff

Most Promising

Most Promising Brand and Quality

National

National Healthcare Excellence Award 2016

Sonu

Excellence in Pharmaceutical & Nutraceutical 2019

Chief

Chief Minister of Maharashtra, Sri Eknath Shinde Ji

Nitin

Shri Nitin Gadkari, Transport & Highways Minister

Gujarat Chief

Gujarat's Chief Minister, Bhupendrabhai Patel Ji,

Sonu Sharma

Mr. Sonu Sharma

Harbajan

Mr. Harbhajan Singh

Sonutwo

Mr. Sonu Sood

Nora Fatehi

Ms. Nora Fatehi

Shivaraj

Mr. Shivaraj Kumar

Anup

Mr. Anup Soni

Sunny

Sunny Leone

Hussain

Hussain Kuwajerwala

Tamanna Bhatia

Tamanna Bhatia

Malaika

Malaika Arora

Tusshar

Tusshar Kapoor

Sreesanth

Mr. S. Sreesanth

Neha Dupia

NEHA DUPIA

Keywords